 |
 |
+++++++++++++++++++++++++++++++++++++++++++++++++ Posted Tue, 8 Jan 2008 17:05:35 This message was forwarded through MEDSOCNEWS. If you wish to make an announcement or publicise an event then please send the text to: [log in to unmask] +++++++++++++++++++++++++++++++++++++++++++++++++ Dear all, Kane Race will be giving a seminar on 'Drugs, Medico-Moralism, and the Use of Pleasure in Harm Reduction' this Thursday 10th at 5pm in the CSISP seminar room, WT1204, Goldsmiths, University of London. All are welcome - please pass this email on to anyone who might find the topic to be of interest. URL: <http://www.goldsmiths.ac.uk/csisp/source/events.html#harmreduction> Forthcoming events in the series will be added later this week. Finally, a happy new year to everyone. Best wishes, Natalie Natalie Warner Research Administrator Centre for the Study of Invention and Social Process (CSISP) Department of Sociology Goldsmiths, University of London New Cross London SE14 6NW Tel: +44 (0)20 7919 7731 Fax: +44 (0)20 7919 7713 Web: www.goldsmiths.ac.uk/csisp ********************************************************************** 1. For general enquires or problems with the list or to CHANGE YOUR EMAIL ADDRESS send a message to: [log in to unmask] 2. To suspend yourself from the list, whilst on leave, for example, send an email to [log in to unmask] with the following message: set medsocnews nomail 3. To resume email from the list, send the following message: set medsocnews mail 4. To leave MedSocNews, send an email to [log in to unmask] with the message (leave the subject line blank and do not include a signature): leave medsocnews 5. To join or subscribe to MedSocNews, send an email to [log in to unmask] with the message (leave the subject line blank and do not include a signature): SUBSCRIBE medsocnews firstname lastname 6. Further information about the medsocnews discussion list (including list archive and how to subscribe to or leave the list) can be found at the list web site: http://www.jiscmail.ac.uk/lists/medsocnews.html **********************************************************************